ESPR filings
Corporate insider profile
Sheldon L. Koenig Filing Activity
Latest reported as President and CEO of Esperion Therapeutics, Inc. (ESPR).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$169,070.14
- Latest transaction
- Jun 17, 2026
Affiliated corporations
Reported company relationships
Transaction history